A dose finding trial with a novel ingenol derivative (ingenol disoxate; LEO 43204) for field treatment of actinic keratosis on full face or 250cm(2) on the chest.
CONCLUSION: Ingenol disoxate gel is efficacious and well tolerated as field treatment for AKs on the full face or chest.
PMID: 28264612 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
More News: Cancer & Oncology | Carcinoma | Dermatology | Pain | Skin | Skin Cancer | Squamous Cell Carcinoma